WeVote
Log In

Bill

Bill

SB 484

Moving marijuana from schedule I to schedule III of the uniform controlled substances act.

2025-2026 Regular Session Introduced by Cindy Holscher

Kansas bill reclassifies marijuana from Schedule I to Schedule III, potentially enabling medical use programs and reducing criminal penalties while creating federal-state legal conflicts.

Died in Committee
#cannabis #crimes #punishmentandcriminalprocedure #healthandhealthcare #uniformacts
0
WeVote Research Nonpartisan
Bill Summary · SB 484

Legislative bill overview

SB 484 proposes to reclassify marijuana from Schedule I to Schedule III under Kansas's Uniform Controlled Substances Act. This would reduce the substance's legal classification from the most restrictive category (no accepted medical use, high abuse potential) to a more permissive one (accepted medical uses, moderate to low abuse potential), aligning with how medications like some barbiturates and anabolic steroids are classified.

Why is this important

Rescheduling marijuana would fundamentally alter Kansas drug enforcement priorities and could open pathways for medical marijuana programs, reduced criminal penalties for possession, and potential tax revenue from regulated sales. It would also signal a significant shift in state drug policy that contrasts with current federal scheduling, which maintains marijuana in Schedule I.

Potential points of contention

  • Federal-state conflict: Marijuana remains Schedule I federally; Kansas rescheduling creates legal ambiguity and potential conflicts with federal enforcement and banking regulations
  • Medical evidence debate: Disagreement over whether marijuana meets the "accepted medical use" standard required for Schedule III, with differing interpretations of existing research
  • Criminal justice implications: Questions about retroactive application—whether this affects past convictions and incarceration, and associated costs of record expungement
  • Implementation concerns: Lack of established regulatory framework for Schedule III substances in Kansas; unclear how licensing, testing, and distribution would operate
  • Public health disagreement: Competing claims about marijuana's risks to adolescent brain development, impaired driving, and gateway drug concerns versus therapeutic benefits

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.